Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124623994 | 12462399 | 4 | F | 20160506 | 20160719 | 20160614 | 20160727 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046007 | BRISTOL MYERS SQUIBB | 71.48 | YR | M | Y | 0.00000 | 20160727 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124623994 | 12462399 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 3 MG, QD | 21436 | 3 | MG | TABLET | QD | ||||||
| 124623994 | 12462399 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | 13840 | MG | Y | 0 | 40 | MG | TABLET | QD | |||
| 124623994 | 12462399 | 3 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 124623994 | 12462399 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1.5 MG, QD | U | 0 | 1.5 | MG | TABLET | QD | |||||
| 124623994 | 12462399 | 5 | C | URIEF | SILODOSIN | 1 | Oral | 8 MG, QD | U | 0 | 8 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124623994 | 12462399 | 1 | Schizophrenia |
| 124623994 | 12462399 | 2 | Product used for unknown indication |
| 124623994 | 12462399 | 3 | Product used for unknown indication |
| 124623994 | 12462399 | 4 | Product used for unknown indication |
| 124623994 | 12462399 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124623994 | 12462399 | HO |
| 124623994 | 12462399 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124623994 | 12462399 | Diabetes mellitus | |
| 124623994 | 12462399 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124623994 | 12462399 | 1 | 20150527 | 0 | ||
| 124623994 | 12462399 | 2 | 20150527 | 20160607 | 0 | |
| 124623994 | 12462399 | 3 | 20150519 | 0 | ||
| 124623994 | 12462399 | 4 | 20141219 | 0 | ||
| 124623994 | 12462399 | 5 | 20150624 | 0 |